Indonesia’s State-Owned Kimia Farma Gears Up To Produce Antiretrovirals Under Compulsory License
This article was originally published in PharmAsia News
Nearly eight months after Indonesia issued a compulsory license to make seven second-line antiretroviral drugs, state-owned PT Kimia Farma does not have a timetable for the sale of the products, though a health ministry official says production trials are underway.
You may also be interested in...
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.
Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.